SB 367 (Hurtado) – Would require each community college district (CCD) and the California State University (CSU), and requests the University of California (UC), to collaborate with campus-based and community-based recovery advocate organizations to provide educational and preventive information about opioid overdose and the use and location of opioid overdose reversal medication on campus as part of each campuses’ established campus orientations. Would also require each CCD and CSU, and requests UC, to apply to use the statewide standing order to distribute dosages of opioid overdose reversal medication and apply to participate in the Naloxone Distribution Project administered by the State.
SB 864 (Melendez) – Would establish “Tyler’s Law,” which requires a general acute care hospital treating a person who is receiving a urine drug screening to include testing for fentanyl in the screening.
SB 872 (Dodd) – Would authorize a county or a city and county to operate a licensed mobile unit to provide prescription medication within its jurisdiction to specified individuals, including those individuals without fixed addresses.
SB 1165 (Bates) – Would clarify existing law to prohibit an operator of an alcoholism or drug abuse recovery treatment facility or program, or a licensed psychiatric or mental health facility, from making false or misleading statements or providing false or misleading information about the facility’s or program’s services.
AB 2122 (Choi) – Would require each campus of a California State University (CSU) and the California Community Colleges (CCC), and request each campus of the University of California (UC), with a campus mental health hotline to have printed on either side of student identification cards the telephone number of their mental health hotline or the city’s or county’s mental health hotline, for which the campus is located, if the campus does not have a campus mental health hotline.
AB 1598 (Davies) – Would exclude from the definition of “drug paraphernalia” any testing equipment that is designed, marketed, used, or intended to be used, to analyze for the presence of fentanyl or any analog of fentanyl, ketamine, or gamma hydroxybutyric acid.